Celecoxib / Celebrex & ctDNA in Stage III Colon Cancer Findings from CALGB Alliance / SWOG 80702 ASCO GI 2025

In an enlightening discussion at the latest medical symposium, Dr. Jonathan Nowak, MD from Brigham and Women’s Hospital, shared critical insights on the role of circulating tumor DNA (ctDNA) and its interaction with celecoxib in treating stage III colon cancer. Here’s a summary of the key points from this session, based on the study titled … Continue reading Celecoxib / Celebrex & ctDNA in Stage III Colon Cancer Findings from CALGB Alliance / SWOG 80702 ASCO GI 2025